CBI Assists Sponsors and Lawyers in Due Diligence for Hipine’s (2583.HK) IPO
On 30 September 2025, Shenzhen Hipine Precision Technology Co., Ltd. (2583.HK, Hipine) successfully listed on the Main Board of the Hong Kong Stock Exchange (HKEx), raising a total of approximately HKD 314 million. CBI is honored to participate in the due diligence work for this IPO Project.
Hipine is a China-based company principally engaged in designing, manufacturing of gold-case watches and gold-bezel watches. The Company’s main products include watches and accessories product portfolio which are sold under the HIPINE brand.
In this IPO project, CBI primarily assisted the sponsor team in conducting due diligence on the company group, its directors, senior management, shareholders, suppliers, customers and distributors. In addition to the basic information such as litigation, bankruptcy, winding-up and media records, CBI also assisted the sponsor team in conducting reputation intelligence, related company search and reference check. The due diligence project mainly covered investigations in China and Hong Kong.
 - Congrats Ad.jpg)
